Clinical Trial Update: Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma [Phase 1]

View source ↗

Summary

This entry reports a Phase 1 clinical trial evaluating vaccine therapy in combination with ganciclovir for malignant mesothelioma. The trial status is listed as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma

Drugs mentioned

• GANCICLOVIR (GANCICLOVIR SODIUM)
• Mesothelioma vaccine

Snippet

Sponsor: Louisiana State University Health Sciences Center in New Orleans | Conditions: Malignant Mesothelioma | Phase 1 | Status: UNKNOWN